Administration of vitamin K does not counteract the ectopic mineralization of connective tissues in Abcc6-/- mice, a model for pseudoxanthoma elasticum

Cell Cycle

Volumn 10, Issue 4, 2011, Pages 701-707

  Jiang, Qiujie ^a   Li, Qiaoli ^a   Grand Pierre, Alix E ^a   Schurgers, Leon J ^b   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Abcc6 knock out mouse; Ectopic mineralization; Gla proteins; Pseudoxanthoma elasticum; Vitamin K

Indexed keywords

FARNOQUINONE; GLUTATHIONE; VITAMIN K GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; ECTOPIC TISSUE; GENE MUTATION; KNOCKOUT MOUSE; MINERALIZATION; MOUSE; NONHUMAN; PSEUDOXANTHOMA ELASTICUM; VITAMIN K DEFICIENCY;

MUS;

EID: 79951873279     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.4.14862     Document Type: Article

References (31)

1. Uitto J, Li Q, Jiang Q. Pseudoxanthoma elasticum - molecular genetics and putative pathomechanisms. J Invest Dermatol 2010; 130:661-70.
2. Jiang Q, Endoh M, Dibra F, Wang F, Uitto J. Pseudoxanthoma elasticum is a metabolic disease. J Invest Dermatol 2009; 129:348-53.
3. -/- and wild-type mice halts progression of ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am J Pathol 2010; 176:1855-62.
4. -/-). J Invest Dermatol 2010; 130:1288-96.
5. Vanakker OM, Martin L, Gheduzzi D, Leroy BP, Loeys BL, Guerci VI, et al. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007; 127:581-7.
6. Li Q, Schurgers LJ, Smith AC, Tsokos M, Uitto J, Cowen EW. Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene. Am J Pathol 2009; 174:534-40.
7. Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm 2008; 78:131-56.
8. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386:78-81. (Pubitemid 27130923)
9. Vanakker OM, Martin L, Schurgers LJ, Quaglino D, Costrop L, Vermeer C, et al. Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. Lab Invest 2010; 90:895-905.
10. Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT, et al. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 2005; 14:1763-73. (Pubitemid 41418048)
11. Klement JF, Matsuzaki Y, Jiang QJY, Terlizzi J, Choi HY, Fujimoto N, et al. Targeted ablation of the ABCC6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 2005; 25:8299-310. (Pubitemid 41263018)
12. Jiang Q, Li Q, Uitto J. Aberrant mineralization of connective tissue in a mouse model of pseudoxanthoma elasticum: Systemic and local regulatory factors. J Invest Dermatol 2007; 127:1392-402. (Pubitemid 46762987)
13. Li Q, Jiang Q, Pfendner E, Váradi A, Uitto J. Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Derm 2009; 18:1-11.
14. Borst P, van de Wetering K, Schlingemann R. Does the absence of ABCC6 (multidrug resistance protein 6) in patients with pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 2008; 7:1575-9.
15. Illiás A, Urbán Z, Seidl TL, Le Saux O, Sinkó E, Boyd CD, et al. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 2002; 277:16860-7. (Pubitemid 34967710)
16. Thijssen HHW, Vervoort LMT, Schurgers LJ, Shearer MJ. Menadione is a metabolite of oral vitamin K. Brit J Nutr 2006; 95:260-6.
17. Rodent Diets: Overview. PMI Nutrition International 1996-2008, [cited 2010 December 21]. Available at: www.labdiet.com/rodent-diet.html.
18. Iwamoto J, Sato Y, Takeda T, Matsumoto H. High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. Nutr Res 2009; 29:221-8.
19. -/-). J Invest Dermatol 2009; 129:1388-94.
20. Li Q, Török L, Kocsis L, Uitto J. Mutation analysis (ABCC6) in a family with pseudoxanthoma elasticum - presymptomatic testing with prognostic implications. Brit J Dermatol 2010; 163:641-3.
21. Verbraak FD. Antivascular endothelial growth factor treatment in pseudoxanthoma elasticum patients. Dev Ophthalmol 2010; 46:96-106.
22. Farjo KM, Ma JX. The potential of nanomedicine therapies to treat neovascular disease in the retina. J Angiogenes Res 2010; 2:21-35.
23. Sherer DW, Singer G, Uribarri J, Phelps RG, Sapadin AN, Freund KB, et al. Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol 2005; 53:610-5. (Pubitemid 41399927)
24. Neldner KH. Pseudoxanthoma elasticum. Clin Dermatol 1988; 6:1-159.
25. Wallin R, Schurgers L, Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thrombosis Research 2008; 122:411-7.
26. Fodor D, Albu A, Poanta L, Porojan M. Vitamin K and vascular calcifications. Acta Physiol Hung 2010; 97:256-66.
27. Anderson ME, Meister A. Intracellular delivery of cysteine. Methods Enzymol 1987; 143:313-25.
28. Chang M, Shi M, Forman HJ. Exogenous glutathione protects endothelial cells from menadione toxicity. Am J Physiol (Lung Cell Mol Physiol 6) 1992; 637-43.
29. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003; 40:531-7. (Pubitemid 38186463)
30. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87:10-7.
31. -/- mice is affected by Ggcx gene deficiency and genetic background - a model for pseudoxanthoma elasticum. J Mol Med 2010; 88:173-81.